Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Sept 2026 for Contineum Therapeutics, Inc., €36k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Carmine Stengone: trading record in brief
Carmine Stengone is a declared insider of Contineum Therapeutics, Inc., with filings sourced from SEC (Form 4). Between 30 June 2026 and 8 September 2026, the trades on record add up to 4 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 8 September 2026 with a transaction (€36k) in Contineum Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Carmine Stengone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,500 shares@ US$16.70CommonSEC144:0001950047-26-009206
2,500 shares@ US$15.490.0066% mcap17.0% of flowCommonSEC144:0001950047-26-007517
2,500 shares@ US$14.560.0063% mcap100.0% of flowCommonSEC144:0001950047-26-006968
10,000 shares@ US$15.000.026% mcap80.5% of flowCommonSEC144:0001950047-26-006666
4 of 4 declarations
